About Candesant
Candesant is a company based in San Francisco (United States) founded in 2016 by Niquette Hunt. Candesant has raised $44.49 million across 2 funding rounds from investors including KCK MedTech, Polaris Partners and Astia. The company has 3 employees. Candesant operates in a competitive market with competitors including Sebacia, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
- Headquarter San Francisco, United States
- Employees 3
- Founders Niquette Hunt
- SectorsHealthcare
- Website candesant.com
- Social LinkedIn X Facebook
- Legal Name Candesant Biomedical, Inc.
- Total Equity Funding$44.49M (USD)
in 2 rounds
- Latest Funding Round$35.36M (USD), Series B
Jun 2023
- InvestorsKCK MedTech
& 3 more
- Employee Count3
Funding Insights of Candesant
Candesant has successfully raised a total of $44.49M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $35.36 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $44.49M
- Total Rounds 2
- Last Round Series B — $35.36M
- First Round $9.13M
(Feb 2020)
- Investors Count 4
All 2 funding rounds of Candesant with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $35.36M | Series B | – | KCK MedTech | |
| Feb 2020 | $9.13M | Series A | – | – | – |
4 investors in total: 4 institutional.
Investors in Candesant
Candesant has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include KCK MedTech, Polaris Partners and Astia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | kckmedtech.com | - | |
US focused venture capital firm | – | polarispartners.com | Boston, United States | |
Women-led startups are funded through stage-agnostic investments and angel networks. | – | astia.org | San Francisco, United States | |
Venture capital firm focused on aerospace, biopharma, consumer, and multiple sectors | – | correlationvc.com | San Francisco, United States |
Investor details for Candesant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Candesant
7 people are tracked at Candesant (6 in leadership, 1 in team); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Niquette Hunt | Founder & CEO | Leadership |
Alexandra Tudoran | Senior Director, Consumer Marketing | Leadership |
Jacob Waugh | Founder and Chief Scientific Officer | Leadership |
Erin Tims | Vice President Clinical Affairs | Leadership |
Mary Beth Kreissler | Chief Financial Officer | Leadership |
Ignacio Avila | Director Of Lean Manufacturing | Leadership |
Carly Siegel | Practice Development Manager | Team |
Complete people profiles for Candesant
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Candesant
3 dated milestones of Candesant across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Candesant is founded.
- Funding First funding round of $9.1M.
- Funding Latest funding round, Series B, of $35.4M.
Competitors of Candesant
Candesant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sebacia, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sebacia.com | 2010 | Duluth, United States | $72.73M | 14 | Develops topical microparticle therapies for dermatological conditions. | |
| photosonixmed.com | 2014 | Ambler, United States | $2.39M | – | Combination Ultrasound & Phototherapy transducer for antibiotic resistant skin infections | |
| lumatherapeutics.com | 2013 | Millbrae, United States | $2.05M | – | Offers coal tar and light combination therapy for effective psoriasis treatment. | |
| nanoceuticals.net | 2018 | Goiania, Brazil | – | – | Nanoparticle-based products for cosmetics and health sectors are developed. | |
| tinyfateraser.com | 2019 | United States | – | – | Sells devices for fat reduction, body shaping, and skin firming online. | |
| samwoongtec.com | 2014 | Seoul, South Korea | – | – | Develops and produces medical injection devices using IT technology. | |
| alvalux.com | 2015 | Liege, Belgium | – | 1 | Develops innovative medical devices focused on scar therapy solutions. | |
| binom-physio.ru | 2017 | Kaluga, Russia | – | – | Offers ultrasound and laser therapy devices for medical and therapeutic applications. | |
| photontoner.com | 2019 | Manchester, United Kingdom | – | – | Develops innovative massage devices for skin tightening. |
Detailed competitors of Candesant
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Candesant
Complete news archive for Candesant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Candesant
10 companies that operate in the same segment as Candesant (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Candesant
Candesant was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Candesant is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Niquette Hunt is the current CEO of Candesant. They have also founded this company.
Candesant is a funded company, having raised a total of $44.49M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9.13M, raised on Feb 2020.
Candesant has 3 employees.
Candesant Biomedical was founded in 2016 in San Francisco, United States, and operates in the biomedical sector. A proprietary non-invasive device, CDX-101, is offered for treating hyperhidrosis by targeting and inactivating overactive sweat glands. The device is applied under the arms like a patch, where alkali metals interact with water to generate energy that reduces sweating and inhibits bacterial growth.
Candesant's top competitors include PhotoSonix Medical, Nano Ceuticals and Sebacia.
Candesant has 4 investors. Key investors include KCK MedTech, Polaris Partners, Astia, and Correlation Ventures.
Candesant operates through Candesant Biomedical, Inc..